Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells

被引:99
作者
Gao, B
Shen, XN
Kunos, G
Meng, QH
Goldberg, ID
Rosen, EM
Fan, SJ
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
[2] Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Radiat Oncol, Mol Oncol Lab, New Hyde Park, NY 11040 USA
关键词
breast cancer susceptibility gene 1; Janus kinase; signal transducer and activator transcription factor 3; breast cancer; prostate cancer;
D O I
10.1016/S0014-5793(00)02430-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germ-line mutations of the breast cancer susceptibility gene 1 (BRCA1) confer a high risk for breast and ovarian cancer in women and prostate cancer in men. The BRCA1 protein contributes to cell proliferation, cell cycle regulation, DNA repair and apoptosis; howe, er, the mechanisms underlying these functions of BRCA1 remain largely unknown, Here, we showed that, in Du-145 human prostate cancer cells, enhanced expression of BRCA1 resulted in constitutive activation of signal transducer and activator transcription factor 3 (STAT3) tyrosine and serine phosphorylation, Moreover, Janus kinase 1 (JAK1) and JAK2, the upstream activators of STAT3, were also activated by BRCA1, Immunoprecipitation assay showed that BRCA1 interacted with JAK1 and JAK2, Blocking STAT3 activation using antisense oligonucleotides significantly inhibited cell proliferation and triggered apoptosis in Du-145 cells with enhanced expression of BRCA1, These findings indicate that BRCA1 interacts with the components of the JAK-STAT signaling cascade and modulates its activation, which may provide a new critical survival signal for the growth of breast, ovarian and prostate cancers in the presence of normal BRCA1, (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 45 条
[1]  
Besser D, 1999, MOL CELL BIOL, V19, P1401
[2]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[3]  
CARCIA R, 1997, CELL GROWTH DIFFER, V8, P1267
[4]  
Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010
[5]  
Chen YM, 1996, CANCER RES, V56, P3168
[6]   JAK-STAT SIGNALING INDUCED BY THE V-ABL ONCOGENE [J].
DANIAL, NN ;
PERNIS, A ;
ROTHMAN, PB .
SCIENCE, 1995, 269 (5232) :1875-1877
[7]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[8]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[9]   BRCA1/2 carriers and endocrine risk modifiers [J].
Eeles, R ;
Kadouri, L .
ENDOCRINE-RELATED CANCER, 1999, 6 (04) :521-528
[10]   BRCA1 inhibition of estrogen receptor signaling in transfected cells [J].
Fan, S ;
Wang, JA ;
Yuan, R ;
Ma, Y ;
Meng, Q ;
Erdos, MR ;
Pestell, RG ;
Yuan, F ;
Auborn, KJ ;
Goldberg, ID ;
Rosen, EM .
SCIENCE, 1999, 284 (5418) :1354-1356